News Focus
News Focus
icon url

Truthsocial

12/01/25 10:36 AM

#195370 RE: SC8 #195368

Everyone notices your failure to supply links to gluestick successful human clinical trials.....

Let's go RDGL soon enough imo and ISOPET now
Bullish
Bullish
icon url

chereb19

12/01/25 10:37 AM

#195371 RE: SC8 #195368

www.isopet.com

That's got to hurt 😂😂👋😂😂👋
icon url

WALLnut

12/01/25 10:41 AM

#195372 RE: SC8 #195368

Exactly! That's what makes IsoPet so powerful right now....it’s growing fast, clinics are lining up, and RDGL is investing heavily to expand it rather than worrying about short-term profit. You basically explained why it’s working.

Early-stage medical tech always scales at cost. That’s how you seed the market, build adoption, and lock in future revenue streams.
So yeah… thank you for pointing out how aggressively IsoPet is expanding. Couldn't have said it better myself.

And calling it a “distraction”?
Totally agree..... it’s distracting everyone with steady growth, more treatments, and a bigger presence every year. Hard to ignore success like that.

Appreciate you highlighting all the momentum again. Keep it coming!


$RDGL
icon url

Pop23

12/03/25 11:51 PM

#195411 RE: SC8 #195368

Come on now — I’m pretty sure you’re holding thousands of shares yourself
icon url

MovedAlong

12/04/25 8:51 AM

#195415 RE: SC8 #195368



🧨 HATER CLAIM:




“It’s been a decade and IsoPet is sold below cost. There’s no path to profitability. FDA doesn’t care about the animal data. IsoPet is a distraction. RDGL is a scam.”








💥 REALITY CHECK (Reply):




False. Here’s the truth:







💬 “Calling RDGL a scam shows ignorance of how biotech cycles and regulatory processes actually work.”


This is a high-risk, high-reward play—yes. But there’s a real product, a real team, and real regulatory work happening.